GS-0151
/ Gilead
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
September 04, 2026
Study of GS-0151 in Participants With Rheumatoid Arthritis
(clinicaltrials.gov)
- P1 | N=65 | Active, not recruiting | Sponsor: Gilead Sciences | Recruiting ➔ Active, not recruiting
Enrollment closed • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology • CRP
February 18, 2026
GS-US-667-6882: Study of GS-0151 in Participants With Rheumatoid Arthritis
(clinicaltrialsregister.eu)
- P1 | N=39 | Recruiting | Sponsor: Gilead Sciences Inc.
New P1 trial • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology
June 05, 2025
Study of GS-0151 in Participants With Rheumatoid Arthritis
(clinicaltrials.gov)
- P1 | N=75 | Recruiting | Sponsor: Gilead Sciences | Not yet recruiting ➔ Recruiting
Enrollment open • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology
March 31, 2025
Study of GS-0151 in Participants With Rheumatoid Arthritis
(clinicaltrials.gov)
- P1 | N=75 | Not yet recruiting | Sponsor: Gilead Sciences
New P1 trial • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology
1 to 4
Of
4
Go to page
1